Cytolytic T lymphocyte responses to metabolically inactivated stimulator cells. II. Effect of a soluble costimulator factor(s) in primary and secondary mixed leukocyte culture |
| |
Authors: | A Kelso W Boyle |
| |
Affiliation: | Department of Microbiology, University of Melbourne, Parkville, Victoria 3052, Australia |
| |
Abstract: | The ability of a concanavalin A-stimulated spleen cell supernatant (“costimulator”) to overcome the effects of impaired CD and LD antigen presentation by metabolically inactivated stimulator spleen cells was examined in the primary and secondary cytolytic T lymphocyte (Tc) response. (i) Cells inactivated by ultraviolet irradiation or mild glutaraldehyde treatment, which were unable to stimulate primary cytolytic activity on their own, generated near maximal responses in the presence of costimulator. The 30-fold lower efficiency of splenic membrane fragments as antigen in primary MLC with the supernatant indicated that the damage to immunogenicity caused by membrane isolation was not equivalent to that caused by uv light and glutaraldehyde, as has previously been assumed. (ii) Comparison of the relative effects of antigen and costimulator demonstrated that costimulator played the dominant regulatory role in primary MLC, increasing sensitivity to suboptimal antigen doses 10- to 30-fold; neither antigen nor the supernatant appeared preferentially to control the strength of the secondary response. (iii) Metabolically inactivated adult and untreated neonatal spleen cells failed to release costimulator activity in response to concanavalin A. However, the ability of the neonatal cells to induce a primary cytolytic response suggested that costimulator production by the stimulator cells themselves is not essential for primary Tc activation, and supports the hypothesis that the lack of primary immunogenicity of inactivated spleen cells reflects their failure to induce costimulator production by the responder population. |
| |
Keywords: | To whom correspondence should be addressed. Present address: Department of Immunology Swiss Institute for Experimental Cancer Research CH-1066 Epalinges Switzerland. |
本文献已被 ScienceDirect 等数据库收录! |
|